An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer’s disease
Year: 2020
Type: article
Abstract: Neuroinflammation has been increasingly recognized to play a critical role in Alzheimer's disease (AD). The epoxy fatty acids (EpFAs) are derivatives of the arachidonic acid metabolism pathway and have anti-inflammatory activities. However, their efficacy is limited because of their rapid hydrolysis by the soluble epoxide hydrolase (sEH). We report that sEH is predominantly expressed in astrocytes and is elevated in postmortem brain tissue from patients with AD and in the 5xFAD β amyloid mouse model of AD. The amount of sEH expressed in AD mouse brains correlated with a reduction in brain EpFA concentrations. Using a specific small-molecule sEH inhibitor, 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), we report that TPPU treatment protected wild-type mice against LPS-induced inflammation in vivo. Long-term administration of TPPU to the 5xFAD mouse model via drinking water reversed microglia and astrocyte reactivity and immune pathway dysregulation. This was associated with reduced β amyloid pathology and improved synaptic integrity and cognitive function on two behavioral tests. TPPU treatment correlated with an increase in EpFA concentrations in the brains of 5xFAD mice, demonstrating brain penetration and target engagement of this small molecule. These findings support further investigation of TPPU as a potential therapeutic agent for the treatment of AD.
Source: Science Translational Medicine
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
Awards: Biomarkers of Exposure to Hazardous Substances, G2896478198, G3565586886, Convergence of tauopathy and Huntington's disease through selective autophagy, Decoding the role of diverse astrocyte populations in aging and AD, G6364469473, Targeting a lipid-mediated pro-longevity pathway as Alzheimer's therapy, G9000302932, Knockin mouse models of Alzheimer's Disease, Bioactive lipids as effectors and indicators of the deleterious effects of environmental exposure on chronic diseases, ROLE OF TFEB IN TAUOPATHY
OpenAlex ID: W3112030344
